Abstract
A 5‐fluorouracil (5‐FU)‐resistant subline of human colon cancer HT‐29 cells was developed by repeated 1‐h exposure in vitro to 5‐FU. This subline (HT‐29/5‐FU/S) had 8‐fold resistance to 5‐FU in a 1‐h exposure assay. However, it had rather increased sensitivity to 5‐FU when assayed after a continuous 96‐h exposure to it. Significantly less 5‐fluorouridine‐5′‐triphosphate was produced in the resistant cells, leading to a lower level of 5‐FU incorporation into the cellular RNA. The reduced activity of orotate phosphoribosyltransferase might explain these results. In contrast, the HT‐29/5‐FU/S cells were more sensitive to the inhibition of in situ thymidylate synthase (TS) by 5‐FU than were the parent cells. The lower in situ TS activity may have made HT‐29/5‐FU/S cells more sensitive to TS inhibition by 5‐FU as compared with the parent cells. The fact that HT‐29/5‐FU/S was more resistant to short‐term 5‐FU exposure but more sensitive to long‐term exposure than the parent line confirmed the existence of different modes of action of 5‐FU, depending on the exposure time.
Keywords: HT‐29 human colon cancer, 5‐Fluorouracil‐resistance, Dual actions of 5‐FU, Exposure time
Full Text
The Full Text of this article is available as a PDF (67.2 KB).
REFERENCES
- 1. ) Ozawa , S. , Sugiyama , Y. , Mitsuhashi , Y. , Kobayashi , T. and Inaba , M.Cell killing action of cell cycle phase‐non‐specific antitumor agents is dependent on concentration‐time product . Cancer Chemother. Pharmacol. , 21 , 185 – 190 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Ozawa , S. , Sugiyama , Y. , Mitsuhashi , J. and Inaba , M.Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells . Cancer Res. , 49 , 3823 – 3828 ( 1989. ). [PubMed] [Google Scholar]
- 3. ) Inaba , M. , Mitsuhashi , J. and Ozawa , S.Kinetic analysis of 5‐fluorouracil action against various cancer cells . Jpn. J. Cancer Res. , 81 , 1039 – 1044 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. ) Inaba , M. and Mitsuhashi , J.Flow cytometric analysis of cell‐killing actions of 5‐fluorouracil in human colorectal cancer cells . Oncol. Res. , 6 , 303 – 309 ( 1994. ). [PubMed] [Google Scholar]
- 5. ) Monks , A. , Scudiero , D. , Hose , C. , Langley , J. , Cronise , P. , Vaigro‐Wolff , A. , Gray‐Goodrich , M. , Campbell , H. , Mayo , J. and Boyd , M.Feasibility of a high‐flux anticancer drug screen using a diverse panel of cultured human tumor cell lines . J. Natl. Cancer Inst. , 83 , 757 – 766 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Grem , J. L. and Fischer , P. H.Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels . Cancer Res. , 46 , 6191 – 6199 ( 1986. ). [PubMed] [Google Scholar]
- 7. ) Peters , G. J. , Laurensse , E. , Leyva , A. , Lankelma , J. and Pinedo , H. M.Sensitivity of human, murine, and rat cells to 5‐fluorouracil and 5′‐deoxy‐5‐fluorouridine in relation to drug‐metabolizing enzymes . Cancer Res. , 46 , 20 – 28 ( 1986. ). [PubMed] [Google Scholar]
- 8. ) Yalowich , J. C. and Kalman , T. I.Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro . Biochem. Pharmacol. , 34 , 2319 – 2324 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Inaba , M. , Mitsuhashi , J. , Sawada , H. , Miike , N. , Naoe , Y. , Daimon , A. , Koizumi , K. , Tsujimoto , H. and Fukushima , M.Reduced activity of anabolizing enzymes in 5‐fluorouracil‐resistant human stomach cancer cells . Jpn. J. Cancer Res. , 87 , 212 – 220 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Aschele , C. , Sobrero , A. , Faderan , M. A. and Bertino , J. R.Novel mechanism(s) of resistance to 5‐fluorouracil in human colon cancer (HCT‐8) sublines following exposure to two different clinically relevant dose schedules . Cancer Res. , 52 , 1855 – 1864 ( 1992. ). [PubMed] [Google Scholar]
- 11. ) Sobrero , A. F. , Aschele , C. , Guglielmi , A. P. , Mori , A. M. , Melioli , G. G. , Rosso , R. and Bertino , J. R.Synergism and lack of cross‐resistance between short‐term and continuous exposure to fluorouracil in human colon adenocarcinoma cells . J. Natl. Cancer Inst. , 85 , 1937 – 1944 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Wang , F.‐S. , Aschele , C. , Sobrero , A. , Chang , Y.‐M. and Bertino , J. R.Decreased folypolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance . Cancer Res. , 53 , 3677 – 3680 ( 1993. ). [PubMed] [Google Scholar]
- 13. ) Copur , S. , Aiba , K. , Drake , J. C. , Allegra , C. J. and Chu , E.Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5‐fluorouracil . Biochem. Pharmacol. , 49 , 1419 – 1426 ( 1995. ). [DOI] [PubMed] [Google Scholar]